Skip to main content

Veracyte, Inc.

VCYT
Exchange
Nasdaq
Industry
Services-Medical Laboratories
SEC CIK
0001384101

In the last 90 days, Veracyte, Inc. insiders filed 0 open-market purchases and 6 sales; 370 institutions reported holding it in 13F filings for Q2 2026, worth $5.23B in total; ARK Invest is the only superinvestor holding it.

Q2 2023 vs. Q1 2023

How the institutions holding Veracyte, Inc. changed between Q1 2023 and Q2 2023.

All holders in Q2 2023All holders in Q1 2023

13F holders of VCYT: Q1 2023 compared with Q2 2023
MeasureQ1 2023Of which not filed for Q2 2023Q2 2023Change
Holders23312320
Shares78.7M1777.1M−1.62M (−2.1%)
Value$1.74B$0$1.96B+$222.1M (+12.8%)

1 institution that held it in Q1 2023 haven't filed for Q2 2023 yet. Not filing isn't selling, so the changes leave them out.

New holders (24)

Institutions that held Veracyte, Inc. at the end of Q2 2023 but not at the end of Q1 2023.

Institutions new to VCYT in Q2 2023
InstitutionSharesValue% of portfolio
Point72 Asset Management, L.P.1,118,066$28.5M0.10%
First Trust Advisors LP137,119$3.49M0.00%
Renaissance Technologies LLC87,299$2.22M0.00%
Man Group plc60,622$1.54M0.00%
Franklin Resources Inc37,738$961.2K0.00%
Point72 Middle East FZE25,371$646.2K0.04%
Efg Capital International Corp.14,337$365.2K0.08%
Marshall Wace, LLP12,022$306.2K0.00%
Cresset Asset Management, LLC11,656$296.9K0.00%
NinePointTwo Capital10,437$265.0K0.10%
Bessemer Group Inc10,290$262.0K0.00%
XTX Topco Ltd9,599$244.5K0.04%
Pictet Asset Management SA8,798$224.1K0.00%
FDx Advisors, Inc.8,586$219.0K0.01%
MML Investors Services, LLC8,547$218.0K0.00%
Harbor Capital Advisors, Inc.1,500$38.2K0.01%
BerganKDV Wealth Management, LLC1,500$38.2K0.00%
Simplex Trading, LLC835$21.0K0.00%
Pinebridge Investments, L.P.816$20.8K0.00%
Quent Capital, LLC500$12.7K0.00%
Psagot Value Holdings Ltd. / (Israel)157$4.00K0.00%
Versant Capital Management, Inc75$1.91K0.00%
Impact Partnership Wealth, LLC48$1.22K0.00%
Comerica Bank10,836$340.00%

Sold out (24)

Institutions that held Veracyte, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.

Not filed for Q2 2023 yet (1)

Institutions that held Veracyte, Inc. at the end of Q1 2023 and haven't filed a 13F for Q2 2023. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding VCYT in Q1 2023 that haven't filed for Q2 2023
InstitutionShares, Q1 2023Value, Q1 2023
Baldrige Asset Management LLC17$0